CLOUGH CAPITAL PARTNERS L P - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$14,040,590
+195.6%
308,178
+163.2%
1.41%
+176.0%
Q1 2023$4,749,576
+21.9%
117,100
+141.9%
0.51%
+141.5%
Q2 2021$3,896,000
-35.1%
48,400
-32.0%
0.21%
-20.9%
Q1 2021$6,005,000
-47.5%
71,200
-50.1%
0.27%
-67.0%
Q4 2020$11,442,000
-19.8%
142,600
-19.6%
0.81%
-20.8%
Q3 2020$14,258,000
-28.1%
177,300
-25.2%
1.03%
-39.4%
Q4 2019$19,823,000
+65.6%
237,060
+73.2%
1.69%
+70.9%
Q3 2019$11,971,000
+22.7%
136,860
+14.9%
0.99%
+3.4%
Q2 2019$9,758,000
+1328.7%
119,150
+673.7%
0.96%
+2026.7%
Q4 2016$683,000
-85.5%
15,400
-84.4%
0.04%
-81.7%
Q3 2016$4,712,000
+767.8%
99,000
+725.0%
0.25%
+748.3%
Q2 2016$543,00012,0000.03%
Other shareholders
BAXTER INTL INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders